 |
Kar-Ming Fung, MD, PhDOU Medical Center PHONE: (405) 271-8001, x37711 E-MAIL: Kar-Ming Fung |
TITLES
Associate Professor
Neuropathology/Surgical Pathology
Director of Neuropathology
Director of Electron Microscopy
EDUCATION
Taipei Medical College
Taipei, Taiwan
MD (1988)
University of Pennsylvania
Philadelphia, Pennsylvania
PhD, Pathology (1994)
Mackay Memorial Hospital
Residency - Anatomic Pathology
New York University
Residency - Anatomic Pathology
University of Pennsylvania
Philadelphia, Pennsylvania
Fellow - Neuropathology
University of Texas
M.D. Anderson Cancer Center
Fellow -
Surgical Pathology
Diplomate - American Board of Pathology
Anatomic Pathology and Neuropathology
Member
American Association of Neuropatholists
International Association of Chinese Pathologists
United States and Canada Academy of Pathology (USCAP)
Research Interests/Sub-Specialty
The biology of brain tumor with special emphasis on the cell proliferation and cell death of medulloblastoma cells and their response to chemotherapeutic drugs.
Honors & Awards
American Association of Neuropathologists (AANP), member of the Professional Affairs Committee. 2007.
American Association of Neuropathologists, Senior Editor and Webmaster of AANP/OREN, the official AANP online education site; supported in part by OUHSC Department of Pathology, and the Armed Forces Institute of Pathology. 2007.
Regents Award for Superior Teaching. 2008.
PUBLICATIONS
Click link for abstract
- Fung KM, Perry A, Payner TD, Shan Y. Rhabdoid glioblastoma in an adult: report of a case. Pathology 2004 36:585-587.
- Fung KM, Diaz EM Jr, El-Naggar AK, Luna MA. Malignant rhabdoid tumor arising from a pleomorphic adenoma. Ann Diagn Pathol. 2004 Jun;8(3):156-61.
- Siami-Namini K, Shuey-Drake R, Wilson D, Francel P, Perry A, Fung KM. A 15-year-old female with progressive myelopathy. Brain Pathol. 2005 Jul;15(3):265-7.
- Penning TM, Steckelbroeck S, Bauman DR, Miller MW, Jin Y, Peehl DM, Fung KM, Lin HK. Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors. Mol Cell Endocrinol. 27 Mar 2006;248(1-2):1828-191.
- Fung K-M, Samara ENS, Wong C, Metwalli A, Krlin R, Bane B, Liu C-Z, Yang JT, Pitha JV, Culkin DJ, Kropp BP, Penning TM, and Lin H-K: Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/ type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr Relat Cancer. 2006 Mar;13(1):169-80.
- Penning TM, Steckelbroeck S , Bauman DR, Miller MW, Jin Y, Peehl DM, Fung K-M, Lin H-K: Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors Mol Cell Endocrinol 27 March 2006;248(1-2):182-191.
- Fung KM, and Trojanwoski JQ. Neuromuscular System. In: Systemic Oncology Section, Weiss L, Ed., The Cancer Handbook, 2nd Edition, Aliosn MR, Editor-In-Chief, John Wiley and Sons, 2007, Chapter 58, page 798-825.
- Chang WP, Downs D, Huang XP, Da H, Fung KM, Tang J. Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization. FASEB J. 2007 Oct;21(12):3184-96.
- Mondalek FG, Lawrence BJ, Kropp BP, Grady BP, Fung KM, Madihally SV, Lin HK: The incorporation of poly(lactic-co-glycolic) acid nanoparticles into porcine small intestinal submucosa biomaterials. Biomaterials 2008 Mar;29(9):1159-66.
- Wang S, Yang Q, Fung KM, Lin HK. AKR1C2 and AKR1C3 mediated prostaglandin D(2) metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells. Mol Cell Endocrinol. 2008 289:60-6.